BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 59 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2023 | $2,640 | – | 800 | +2185.7% | 0.00% | – |
| Q3 2022 | $0 | – | 35 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 35 | -94.7% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 666 | -4.9% | 0.00% | – |
| Q4 2020 | $3,000 | -75.0% | 700 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -7.7% | 700 | -37.8% | 0.00% | – |
| Q2 2020 | $13,000 | +116.7% | 1,125 | -17.6% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 1,365 | -4.2% | 0.00% | – |
| Q4 2019 | $6,000 | -45.5% | 1,425 | -48.4% | 0.00% | – |
| Q3 2019 | $11,000 | – | 2,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
| ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
| CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
| Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
| Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
| WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
| IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |